세계의 비타민 D 시장 : 예측(2025-2030년)

The global vitamin D market is expected to grow at a 5.88% CAGR, achieving USD 2.351 billion by 2030 from USD 1.767 billion in 2025.

Vitamin D is an essential fat-soluble vitamin critical for optimal physiological function and the maintenance of overall health. The commercial market is primarily composed of two bioactive forms: vitamin D3 (cholecalciferol), which is sourced from animal-derived products such as fish oils, egg yolks, and dairy, and vitamin D2 (ergocalciferol). Vitamin D3 plays a particularly vital role in the body's absorption of calcium and phosphorus, thereby supporting fundamental processes like bone mineralization and immune system function. Commercially, vitamin D3 is formulated into standardized potencies and is available in both oil-based and powder delivery systems, targeting a diverse range of consumer segments including adults, pregnant women, and pediatric populations.

The expansion of the global vitamin D market is propelled by a confluence of key factors. Increasing consumer awareness of the nutritional health benefits associated with vitamin D, coupled with rising disposable income in developed markets and widespread product availability across various retail and pharmaceutical distribution channels, forms a strong foundation for growth. A notable trend is the enhanced consumer spending on preventive healthcare, particularly in developed regions, which has accelerated the adoption of vitamin D supplements. This environment has been further shaped by government-mandated food fortification programs, which have transformed the dietary supplement landscape. Formulations are becoming increasingly sophisticated and targeted toward specialized demographic segments, including prenatal and postnatal nutrition, geriatric health, and pediatric supplementation. The growing body of scientific evidence supporting the benefits of vitamin supplementation has also fostered positive industry sentiment and regulatory acceptance, creating a favorable market climate.

A significant and disease-driven market opportunity stems from the increasing global prevalence of osteoporosis, a condition characterized by decreased bone mineral density and compromised bone microarchitecture that leads to a higher risk of fractures. This condition is particularly prevalent among post-menopausal women, with risk factors including genetic predisposition, low body mass index, and hormonal changes. Given vitamin D's essential role in calcium and phosphorus absorption, it is a cornerstone for maintaining bone health and managing osteoporosis in this demographic. The substantial number of individuals affected by this condition creates a persistent and substantial demand for vitamin D therapeutics and preventive supplements.

Concurrently, innovation in product development is acting as a powerful market catalyst. The introduction of advanced, fast-acting vitamin D formulations is driving market expansion by offering improved bioavailability and a faster therapeutic response compared to conventional supplements. These next-generation products are designed to effectively address severe vitamin D deficiencies and accelerate patient recovery timelines. Leading manufacturers are prioritizing the development of these rapid-absorption supplements to capture market share, with such innovations demonstrating significantly faster efficacy in achieving therapeutic serum levels, thereby supporting goals like immune function optimization more rapidly.

From a geographical perspective, the Asia Pacific region maintains the largest market revenue share and is projected to sustain this leadership position throughout the forecast period. Regional growth is underpinned by abundant raw material availability, particularly from the dairy sector, and consistently rising consumer disposable income. Furthermore, specific regional health challenges, such as higher rates of vitamin D deficiency linked to the prevalence of non-communicable diseases in certain countries, create significant market opportunities for both therapeutic and preventive vitamin D products.

The North American market is also anticipated to experience substantial growth, largely driven by increased consumer awareness of the health benefits of vitamin D. However, the region concurrently faces significant nutritional challenges, with widespread vitamin D deficiency reported due to inadequate dietary intake. This public health issue presents a clear demand driver for supplementation and fortified food products, ensuring a dynamic and growing market in the region.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

• GLOBAL VITAMIN D MARKET BY ANALOG TYPE
• Vitamin D2
• Vitamin D3
• GLOBAL VITAMIN D MARKET BY APPLICATION
• Animal feed & pet food
• Functional food & beverages
• Personal care
• Pharmaceuticals
• GLOBAL VITAMIN D MARKET BY END-USER
• Children
• Adults
• Pregnant Women
• GLOBAL VITAMIN D MARKET BY GEOGRAPHY
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL VITAMIN D MARKET BY ANALOG TYPE

• 5.1. Introduction
• 5.2. Vitamin D2
• 5.3. Vitamin D3

6. GLOBAL VITAMIN D MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Animal feed & pet food
• 6.3. Functional food & beverages
• 6.4. Personal care
• 6.5. Pharmaceuticals

7. GLOBAL VITAMIN D MARKET BY END-USER

• 7.1. Introduction
• 7.2. Children
• 7.3. Adults
• 7.4. Pregnant Women

8. GLOBAL VITAMIN D MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. BASF
• 10.2. DSM
• 10.3. Fermenta Biotech Ltd.
• 10.4. Zhejiang Medicine Co., Ltd.
• 10.5. Zhejiang Garden Biochemical High-Tech Co., Ltd
• 10.6. Glanbia
• 10.7. Nestle SA
• 10.8. Pfizer, Inc.
• 10.9. Zhejiang Xinhecheng Co., Ltd
• 10.10. McKinley Resources Inc.

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations